335 related articles for article (PubMed ID: 38774648)
1. Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.
Han Y; Tian X; Zhai J; Zhang Z
Front Cell Dev Biol; 2024; 12():1363121. PubMed ID: 38774648
[TBL] [Abstract][Full Text] [Related]
2. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
3. Inducing immunogenic cell death in immuno-oncological therapies.
Ti D; Yan X; Wei J; Wu Z; Wang Y; Han W
Chin J Cancer Res; 2022 Feb; 34(1):1-10. PubMed ID: 35355932
[TBL] [Abstract][Full Text] [Related]
4. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
5. Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors.
Cho H; Kim K
Expert Opin Drug Deliv; 2024 Apr; 21(4):627-638. PubMed ID: 38682272
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
[TBL] [Abstract][Full Text] [Related]
7. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
8. Research progress in inducing immunogenic cell death of tumor cells.
Xie D; Wang Q; Wu G
Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
[TBL] [Abstract][Full Text] [Related]
9. Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy.
Zhang MR; Fang LL; Guo Y; Wang Q; Li YJ; Sun HF; Xie SY; Liang Y
Int J Nanomedicine; 2024; 19():3387-3404. PubMed ID: 38617801
[TBL] [Abstract][Full Text] [Related]
10. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
[TBL] [Abstract][Full Text] [Related]
11. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.
Thiruppathi J; Vijayan V; Park IK; Lee SE; Rhee JH
Front Immunol; 2024; 15():1375767. PubMed ID: 38646546
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
Jiang Q; Zhang C; Wang H; Peng T; Zhang L; Wang Y; Han W; Shi C
Front Oncol; 2019; 9():1196. PubMed ID: 31781498
[TBL] [Abstract][Full Text] [Related]
13. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
14. Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy.
Moon Y; Cho H; Kim K
Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931916
[TBL] [Abstract][Full Text] [Related]
15. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies.
Hernández ÁP; Juanes-Velasco P; Landeira-Viñuela A; Bareke H; Montalvillo E; Góngora R; Fuentes M
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198850
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analyses of immunogenic cell death-derived gene signatures: Potential biomarkers for prognosis and immunotherapy.
Han X; Song D; Cui Y; Shi Y; Gu X
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2073. PubMed ID: 38627900
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
18. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches.
Elzoghby AO; Samir O; Emam HE; Soliman A; Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Nasr ML
Acta Pharm Sin B; 2024 Jun; 14(6):2475-2504. PubMed ID: 38828160
[TBL] [Abstract][Full Text] [Related]
19. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
[TBL] [Abstract][Full Text] [Related]
20. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
